Life Sciences Venture Fund
BDC Capital
◆ Investment Thesis
Aimed at supporting early-stage companies in therapeutics and medical technologies to help them transition from research and development to commercialization, addressing funding gaps and retaining scientific talent in Canada.
◆ About BDC Capital
BDC Capital's Life Sciences Venture Fund is a $150 million CAD fund targeting seed- and early-stage (Series A) Canadian companies in therapeutics and medical technologies. It provides patient capital to address funding gaps in capital-intensive sectors requiring hardware and regulatory approvals. The fund aims to back 10-15 companies, accelerating their path from lab to market.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Life Sciences Venture Fund invest in?
Life Sciences Venture Fund invests in Biotech, Medtech and Drug Discovery at the pre-seed, seed and series-a stages.
Which geographies does Life Sciences Venture Fund focus on?
Life Sciences Venture Fund focuses on Canada, and is headquartered in Canada.
What is Life Sciences Venture Fund's typical check size?
Life Sciences Venture Fund typically writes checks of $0.7M to $6M.